Synergistic antiviral activity of interferon-α2b and ribavirin against a surrogate virus of hepatitis C.

被引：0
|
作者：
Lau, J [1 ]
Ingravallo, P [1 ]
Skelton, A [1 ]
Hajian, G [1 ]
Zhong, W [1 ]
Hong, Z [1 ]
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
117
引用
收藏
页码：190A / 190A
页数：1
相关论文
共 50 条
  • [41] Celgosivir and castanospermine are highly synergistic against bovine viral diarrhea virus when combined with interferon alpha 2b or with interferon alpha 2b and ribavirin
    Dugourd, Dominique
    Siu, Raymond
    Fenn, Jeremy
    ANTIVIRAL RESEARCH, 2006, 70 (01) : A56 - A56
  • [42] Combination therapy with interferon-α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection
    Hung, CH
    Lee, CM
    Lu, SN
    Wang, JH
    Tung, HD
    Chen, CH
    Changchien, CS
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (05) : 727 - 732
  • [43] High-dose interferon-α2b plus ribavirin for retreatment of interferon-nonresponsive patients infected with genotype 1 hepatitis C virus
    Buti, M
    Morral, S
    Sanchez, F
    Martell, M
    Stalgis, C
    Esteban, R
    DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (11) : 2396 - 2400
  • [44] Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection
    Tsubota, A
    Hirose, Y
    Izumi, N
    Kumada, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 360 - 367
  • [45] The metabolism, pharmacokinetics and mechanisms of antiviral activity of ribavirin against hepatitis C virus
    N. M. Dixit
    A. S. Perelson
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 832 - 842
  • [46] Interferon-α2b therapy in low-activity hepatitis C:: A pilot study
    Nordoy, I
    Krarup, HB
    Bell, H
    Christensen, PB
    Elgjo, K
    Von der Lippe, B
    De Muckadell, OS
    Maeland, A
    Ring-Larsen, H
    Samdal, HH
    Simmonds, P
    Skaug, K
    Tage-Jensen, U
    Schrumpf, E
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (12) : 1256 - 1260
  • [47] High-Dose Interferon-α2b Plus Ribavirin for Retreatment of Interferon-Nonresponsive Patients Infected with Genotype 1 Hepatitis C Virus
    Maria Buti
    Sergio Morral
    Francisco Sanchez
    Maria Martell
    Carlos Stalgis
    R. Esteban
    Digestive Diseases and Sciences, 2001, 46 : 2396 - 2400
  • [48] Modeling the Antiviral Activity of Ribavirin Against Hepatitis C Virus in Cell Culture
    Felmlee, Daniel J.
    Xiao, Fei
    Baumert, Thomas F.
    HEPATOLOGY, 2013, 58 (04) : 1203 - 1206
  • [49] Early prediction of nonresponders to treatment with interferon alpha 2B and Ribavirin in patients with chronic hepatitis C.
    Liu, LWC
    Tomlinson, G
    Mazulli, T
    Heathcote, J
    HEPATOLOGY, 2000, 32 (04) : 357A - 357A
  • [50] Preliminary report:: Efficacy of high dose daily induction interferon α-2b plus ribavirin followed by continuing daily interferon α-2b plus ribavirin in the treatment of hepatitis C.
    King, JW
    Favrot, DR
    Markanday, A
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
12345